LicianPro

KZR stock

Kezar Life Sciences Inc (KZR) stock news · $53.9M cap

Kezar Life Sciences Inc (KZR) is a biotechnology company listed on NASDAQ.

This KZR news page leads with what Kezar Life Sciences Inc filed — not a scraped headline mill.

No cached 8-K sentence for KZR yet. We will not pad this page with generic market recap.

Latest reported KZR revenue for 2025-12-31 was $0. Net income was -$56.0M. KZR currently screens at market cap $53.9M.

EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.

Not investment advice. For the model open the KZR stock page; for the tape open the quote page.

KZR stock news FAQ

What is KZR's latest net income?

Latest cached Kezar Life Sciences Inc (KZR) net income was -$56.0M. Statements: https://lician.com/financials/kzr

What is KZR's market cap?

Kezar Life Sciences Inc (KZR) market cap is $53.9M on the latest cached fundamentals snapshot.

What kind of company is KZR?

Kezar Life Sciences Inc (KZR) is a biotechnology company listed on NASDAQ.

Where is KZR stock news listed?

Cached stock news for Kezar Life Sciences Inc (KZR) is listed at https://lician.com/news/kzr. Filings: https://lician.com/sec/kzr

Not investment advice.

Full KZR analysis